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Background and Objectives: Fractional ablation offers
the potential benefits of full-surface ablative skin resurfac-
ing while minimizing adverse effects. The purpose of
this study was to evaluate the safety, damage profile, and
efficacy of erbium fractional lasers.
Materials and Methods: Histology from animal and
human skin as well as clinical evaluations were conducted
with erbiumYAG (2,940 nm) and erbiumYSGG (2,790 nm)
fractional lasers varying pulse width, microbeam (mb)
energy, number of passes, and stacking of pulses.
Results: Single-pulse treatment parameters from 1 to
12 mJ per 50–70 mm diameter microbeam and 0.25–
5 milliseconds pulse widths produced microcolumns of
ablation with border coagulation of up to 100 mmwidth and
450 mm depth. Stacking of pulses generated deeper micro-
columns. Clinical observations and in vivo histology
demonstrate rapid re-epithelization and limited adverse
side effects. Facial treatments were performed in the
periorbital and perioral areas using 1–8 passes of
single and stacked pulses. Treatments were well-tolerated
and subjects could resume their normal routine in 4 days.
A statistically significant reduction in wrinkle scores at
3 months was observed for both periorbital and perioral
wrinkles using blinded grading. For periorbital treatments
of four passes or more, over 90% had 1 score wrinkle
reduction (0–9 scale) and 42% had 2. For perioral
wrinkles, over 50% had substantial improvements (2).
Conclusion: The clinical observations and histology
findings demonstrate that micro-fractional ablative
treatment with 2,790 and 2,940 nm erbium lasers resulted
in safe and effective wrinkle reduction with minimal
patient downtime. The depth and width of the ablated
microcolumns and varying extent of surrounding coagu-
lation can be controlled and used to design new treatment
procedures targeted for specific indications and areas
such as moderate to severe rhytides and photodamaged
skin. Lasers Surg. Med. 40:113–123, 2008.
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INTRODUCTION
Treatment of photoaged skin with ablative lasers has
been shown to produce clinically efficacious results in a
number of studies [1–4]. However, these procedures are
painful, have significant downtime and adverse side effects
such as infection, pigment alterations, long-lasting eryth-
ema, and scarring [5–9]. The downtime from the recovery
process encompasses both the time for physiological
processes associated with re-epithelization to occur and
the time needed for the patient to return to normal activity
without any psychological discomfort resulting from the
appearance of the treated areas. Full-surface ablative
procedures with aCO2 laser, for example, have been shown
to produce 1–2weeks of downtimeand erythema lasting for
an average of 2–4.5 months [5]. Extended downtime and
long-lasting erythema are obvious drawbacks for patients
undergoing this procedure.
Recent application of fractional technology to non-
ablative skin rejuvenation techniques has potential to
provide efficacy while maintaining advantages of minimal
to no downtime. Fractional non-ablative treatments have
been useful in treating conditions such asmild tomoderate
rhytides [10], photodamaged skin [11], acne scarring
[12,13], leucodermic scars [14], melasma [15,16], and non-
facial skin rejuvenation [17]. Investigators have reported
re-epithelization in 24 hours with this procedure [18,19],
thereby reducing downtime for the patient. Furthermore,
there has been a noted absence of the side effects typically
associated with full-surface ablation [9]. However, despite
these safety advantages the clinical efficacy profile does not
match that of the full ablative process, especially with
respect to moderate to severe rhytides [10].
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Fractional ablative procedures have the potential to
provide greater efficacy for treatment of rhytides,
while minimizing downtime and side effects. Fractional
ablative CO2 lasers have been shown to reduce downtime
and result in more rapid wound healing [20–24]. The
reliability and compactness of the Er:YAG, and Er:YSGG
laser sources are also worth consideration, particularly if
they can be adapted to provide ablation with a sufficient
residual layer of tissue coagulation. Interaction between
laser light and tissue in the ablative regime is dominated by
water absorption; therefore, the water absorption coeffi-
cient is a major factor in wavelength selection. The water
absorption coefficients for the three above-mentioned
wavelengths differ by an order of magnitude (103 cm1
for CO2 laser at 10,600 nm, 10
4 cm1 for Er:YAG laser at
2,940 nm, and 102 cm1 for Er:YSGG laser at 2,790 nm).
Even though there is considerable knowledge on skin
ablation with wide beams, the interaction of microbeams
with tissue can be substantially different, due to vast
increases in local intra-beam power density and fluence.
Another important factor that governs the formation of
ablative and coagulative zones is the pulse width. In this
work, we compared the effects of Er:YAG and Er:YSGG
lasers using both short- and long-pulse modes in order
to optimize ablative fractional device parameters for new
treatment regimens.
MATERIALS AND METHODS
Device Description
Two unique erbium fractional lasers were developed as
accessories to the StarLuxTM Pulsed Light & Laser System
platform (Palomar Medical Technologies, Inc., Burlington
MA). Each laser consists of an active rod pumped by a
Xenon flash lamp: an erbium-doped Yttrium Aluminum
Garnet crystal (Y3Al5O12, Er:YAG) emitting at 2,940 nm
and an erbium-doped Yttrium Scandium Gallium Garnet
(Y2.93Sc1.43Ga3.64O12, Er:YSGG) emitting at 2,790 nm. One
of the fractional handpieces is shown in Figure 1.
The fractional beam emission pattern of the laser is user
selectable by an interchangeable optical tip. The ‘‘fractional’’
pattern consists of an array of focused microbeams (75 mm
diameter) that have up to 12 mJ/mb of energy with a beam
density from 170 to 1,000 mb/cm2 (illustrated in Fig. 2). The
number of microbeams delivered to the skin depends upon
the spot size, the distance between the microbeams (i.e.,
microbeam pitch) as well as the number of passes.
Histology
Six millimeter punch biopsies from ex vivo Yucatan pig
and human abdomen skin were used to characterize the
damage profile after treatment with the erbium fractional
lasers. Series of 2 mm punch biopsies were also collected
from the periauricular area of the face at various time
points after in vivo treatment with the erbium fractional
lasers to demonstrate healing responses.
For the ex vivo skin testing, abdominal skin of the
Yucatan pig was harvested and treated within 24 hours of
excision. Human abdominal skin was obtained following
abdominoplasty and stored frozen for 2 days prior to
treatment. Porcine and human skin samples maintained
Fig. 1. Erbium Lux2940 _ fractional laser.
Fig. 2. Fractional versus flat beam erbium ablation.
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at 308C with a warming plate were treated at parameters
summarized inTable 1a. Sampleswere fixed in formalin for
serial sectioning and staining with hematoxylin and eosin
(H&E) in preparation for histologic examination.
For in vivo human histology, the healing response was
characterized using 26 biopsies collected from 4 subjects
at various time points after facial treatment. Table 1b
summarizes the treatment parameters and time of biopsies.
All subjects consenting to these biopsies were scheduled for
a facelift procedure.
Clinical Procedures
Subjects. The clinical study involved 108 treated areas
across a total of 13 subjects with mild to moderate photo-
damaged and aged facial skin. Fitzpatrick skin types
ranged from I to III and the participants ages ranged from
33 to 62. Testing was performed with FDA approval.
Informed consent was obtained from all subjects, and the
study was approved by the Essex Institutional Review
Board of Lebanon, NJ.
Treatment procedure. Subjects were treatedwith the
2,940nmerbium fractional laser using parameters ranging
from 1 to 9 mJ/mb and a pulse width varying from 250
microseconds to 5 milliseconds. Subjects were also treated
with the 2,790 nm handpiece using parameters ranging
from 4 to 12 mJ/mb and a pulse width varying from 2 to
5 milliseconds. Areas were treated with multiple passes
varying from 1 to 8 total passes and included passes with
stacked pulses.
If needed, treatments were applied with topical anes-
thetic or adjunctive cooling. In several instances, the
treated areas were subdivided into smaller areas in
order to evaluate a range of parameters, while in the other
treated areas the region was treated uniformly with a
single parameter. Subjects were instructed to clean and
apply ointment to treated areas three times daily for 4 days
after treatment.
Clinical evaluations. A total of 108 treatment areas
were evaluated for wound healing and side effects imme-
diately post-treatment and at 3 follow-up visits: 3–4 days,
1 week, and 1–3 months post-treatment. Included in the
evaluations were 21 periorbital and 19 perioral areas for
assessment of wrinkle reduction. At all observational time
points, side effects of erythema, edema, bruising, debris,
crusting, bleeding, hyper- andhypopigmentation, scarring,
atrophy, blistering were evaluated on a 9 point scale
(0¼none, 1–3 mild, 4–6 moderate, and 7–9 severe).
During treatment, subjects rated pain on a 0–10 scale to
help evaluate procedure safety and patient tolerance.
Wrinkle appearance 3 months after the single treatment
was evaluated on a 0–9 scale in a randomized, blinded
side-by-side fashion by three dermatologists. A stand-
ardized t-test and Wilcoxon signed-rank statistic were
conducted on the difference score (post-pre) using JMP 7
(SAS Institute, Cary, NC).
Photo documentation system. All photographic doc-
umentationwas performedwith a facial photo fixture using
a NikonD100 and a Canon PowerShot S2 stand-off camera
(Canfield Scientific, Fairfield, NJ). The fixture ensured a
fixed distance and fixed angles between the camera and the
patient. Flash lamps placed in fixed positions to the camera
ensured even illumination of all parts of the face and the
ability to examine subjects under controlled lighting.
RESULTS
Histologic Findings
Porcine ex vivo histology. Figures 3–5 depict three
porcine skin histology slides that demonstrate micro-beam
ablation and coagulation after single-pulse treatments
TABLE 1a. Ex Vivo Single-Pass Treatment Parameters
Wavelength (nm) Energy (mJ/mb) Pulse width (milliseconds) Stacked pulses
2,790 4–12 2–5 Up to 3
2,940 1–9 0.25, 2, 5 Up to 3
TABLE 1b. In Vivo Single-Pulse Treatment Parameters and Biopsy Time Points for Histology
Subject Biopsy #
Wave-
length
Energy
(mJ/mb)
Pulse width
(milliseconds)
Biopsy time (days)
0 1/4 1/2 1 2 4 7 14 21 28
S#1 1–10 2,940 9 0.25 (@) (@) (@) (@) (@) (@) (@) (@) (@) (@)
S#4 11–18 2,790 12 5 (@) (@) (@) (@) (@) (@) (@) (@)
S#5 19 2,790 8 5 (@) (@)
20 2,790 8 2 (@) (@)
21 2,940 5 5 (@) (@)
22 2,940 5 2 (@) (@)
S#6 23 2,790 8 5 (@) (@)
24 2,790 8 2 (@) (@)
25 2,940 5 5 (@) (@)
26 2,940 5 2 (@) (@)
All biopsies were taken from the periauricular area of the face. The ‘‘zero’’ column for biopsy time refers to immediate post-
treatment.
MICRO-FRACTIONAL ABLATIVE SKIN RESURFACING 115
with the 2,790 nm wavelength and 2,940 nm wavelength
laser devices. Figure 3 shows a horizontal section at 60–
100 mmdepth of skin treated with the 2,790 nm device. The
treatment parameters were 8 mJ/mb and 2 milliseconds
pulsewidth.Figures4and5exhibit similardamageprofiles
after treatmentwith the2,940nmwavelengthdevice (5mJ/
mb with 2 milliseconds and 0.25 milliseconds pulse widths,
respectively).
Human ex vivo histology. Figure 6 depicts typical
histology obtained after treatment of excised human
abdominal skinwith the 2,940 nmdevice. The approximate
intra-beam fluence for the 0.25 milliseconds pulse treat-
ment is 60 J/cm2, which is significantly greater than the
ablation threshold fluence. By increasing pulse width to
5 milliseconds at the same energy, the erbium laser
generated ablated columns with wider surrounding zones
of coagulation as shown in Figure 6.
Incremental increase in depth of damage was achieved
with either increasing energy, decreasing pulse width for
fixedmicrobeam energy, ormultiple stacking of pulses. For
example, for the long-pulse mode (2–5 milliseconds), the
depths of microcolumn damage, ablation plus coagulation,
increased in a linear fashion from 50 to 140 mm at settings
from 1 to 5mJ/mb. Over the same rangemicrocolumns from
the short-pulse mode (0.25 milliseconds) were 20 to 25%
deeper. Average depths of over 250 mm were observed
with stacking of 2–3 pulses at a 2 Hz repetition rate with
2 milliseconds pulse widths and 5 mJ/mb.
Human in vivo tissue healing. The tissue healing
response was evaluated from the time series of biopsies
taken from the periauricular region after a single-pass
treatment. The histology findings for the 2,940 nm wave-
length treatment are shown in Figure 7 and indicate that
within 12 hours there is a very rapid re-epithelization
(Fig. 7c). For 2,790 nm treatment, re-epithelization was
observed at the shortest post-treatment biopsy time of
24 hours. Re-epithelization was noted as a continuous
dermal/epidermal junction with an overlying continuous
layer of basal cells in all serial sections through the micro-
column zones. At 12 and 24 hours, the damage zones
could be identified with dermal collagen coagulation or
by columnar-shaped regions of neutrophillic infiltration
associatedwith inflammation (Fig. 7c, 24 hours not shown).
At a few days following treatment, necrotic debris was
observed entrapped in the upper epidermis above the
micro-columns.
Fig. 3. a: Longitudinal section at 60–100 mmdepth of Yucatan pig skin treated with the 2,790
nm laser device at 8 mJ/mb and 2 milliseconds pulse width. b: Magnified image of one micro-
channel with 40 mm diameter ablation zone surrounded by a 20 mm thick coagulation zone.
Fig. 4. a: Longitudinal section at 50–80 mm depth of Yucatan pig skin treated with 2,940 nm
laser (5 mJ/mb and 2 milliseconds pulse width). b: Magnified micro-channel with a 60 mm
diameter ablation hole surrounded by 15 mm thick coagulated layer.
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Clinical Findings
Safety. A total of 85 treatment areas were observed for
side effects and healing during the first week after treat-
ment. Skin reactions anddiscomfort from fractional erbium
YSGG (2,790 nm) and erbium YAG (2,940 nm) treatments
were mild, transient, and short-lasting when compared to
traditional full-surface ablative resurfacing. As early as
4 days after treatment, subjects could apply make-up and
resume their normal hygiene routines.
Pain ratings show that for small test areas the procedure
was well-tolerated without anesthetics. With greater
number of passes and treatment of larger areas, topical
anesthesia and adjunctive cold air were typically used.
A maximum pain rating of 4 or less was observed in
periorbital treatments. For most subjects, pain ratings
increased by 1 U with additional passes. Perioral treat-
ments were less painful, with an overall rating of 3 or less,
and ratings did not increase with additional passes.
Table 2 summarizes the skin reactions observed after the
erbium fractional treatment with the 2,940 and 2,790 nm
wavelength devices using short- and long-pulse modes,
0.25 milliseconds and 2 or 5 milliseconds, respectively.
Minorbleedingwithedemawasobservedonlywith the2,940
nm device treatments. Consistent with the histology find-
ings of wider coagulation zones, only sparse and pin-point
bleeding was observed with the longer pulse widths, in
comparison to the mild diffuse bleeding from areas treated
with the 0.25 milliseconds pulse width. Immediately after
treatment nearly all subjects developed mild or moderate
erythema, with predominance of mild erythema. The
incidence of erythema was markedly reduced by week 1,
Fig. 5. Cross-section of Yucatan pig skin treated with the 2,940 nm laser at 5 mJ/mb and
0.25milliseconds pulsewidth. The damageprofile extends down to 170 mmwith approximately
a 15 mm thick coagulation zone surrounding the ablation column.
Fig. 6. Cross-sections of ex vivo human abdominal skin treated with the 2,940 nm laser at
5 mJ/mb and (a) 5 milliseconds and (b) 0.25 milliseconds pulse widths. Note the increase in
coagulation layer thickness for the 5 milliseconds parameter.
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with mostly trace and mild ratings for either of the two
wavelengths. For the 2,940 nm treatments with 4 or greater
passes, mild post-inflammatory erythema was present at
3months post-treatment in 2 of 12 periorbital areas and in 2
of 7 perioral areas (Tables 3a and 3b). For the 2,790 nm
periorbital treatments, two of four tests with one to two
passes had post-inflammatory erythemapresent at 1- and 3-
month observations.
Although the immediate skin reactions increased in some
cases from mild to moderate with increasing passes, the
overall time course and speed of healing were similar. All
treatment areas showed thepresence of necrotic debris that
sloughed off by day 4 revealing pinkish healthy skin. Other
skin reactions included an instance of bruising under the
eye and burning discomfort lasting for just over 12 hours.
For the 39 treatment areas observed for at least 1 month,
therewere no incidents of hyper- or hypopigmentation. The
remaining treatment areas were not available for observa-
tions after 1 week due to planned facelift procedures.
Clinical observations. For all areas treated with the
fractional erbium laser,well-definedmicrobeamcolumns of
ablation were evident immediately at the skin surface
that over the course of the next few days were replaced by
necrotic debris. At the end of 1 week natural skin texture
was restored. An example of the surface appearance of skin
from the microbeam 2,940 nm fractional ablation using
5 mJ/mb at 2 milliseconds pulse width and the time course
of healing are shown in Figure 8.
The time course of skin reactions and the healing from
multi-pass treatment with the 2,940 nm handpiece are
illustrated in Figure 9. The subject received periorbital
treatmentof four passes of 920mb/cm2per pass, eachat 5mJ/
mb at 5 milliseconds pulse width. The sequence of pictures
was taken before, immediately after, and at 4, 7, and 14 days
post-treatment.The oozing that is evident immediately after
treatment resolved and necrotic tissue was replaced with a
faint pink skin by day 4 (top right Fig. 9). Natural healthy
skin tone and texture was fully restored by 1 week (bottom
left Fig. 9). This subject’s reactions are representative of the
tested parameters and show a rapid healing and restoration
of the skin consistent with the rapid re-epithelization
observed in the biopsy time series.
Efficacy of treatments from 21 periorbital areas and
19 perioral areas was examined at 3 months. Because
TABLE 2. Side Effects Observed Immediately After Treatment
Erbium fractional laser
wavelength Pulse width (milliseconds) Bleeding or oozing Edema Lingering sensitivity
2,940 nm (n¼ 36) 0.25 100% mild 100% mild 8% mild
2–5 52% mild 43% mild 28% mild
2,790 nm (n¼ 49) 2–5 None None 20%mild, 4%moderate
Fig. 7. H&Ehistology at three time points post-treatmentwith 2,940 nmdevice at 9mJ/mb, and
0.25milliseconds illustrate rapid healing response tomicrobeamdamage zones.a: Immediately
post-treatment a 450 mmdeep ablation channel is observedwith a surrounding thin coagulation
zone. Note the angle of the section missed the ablated epidermis. b: Six hours post-treatment
biopsy reveals partial re-epithelization of the epidermiswith significant inflammatory response
within and surrounding the microchannel. c: At 12 hours post-treatment, the epidermis has
completely re-epithelized and necrotic debris is observed at the skin surface.
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TABLE 3a. Periorbital Wrinkle Reduction After Micro-Fractional Erbium Treatment
Handpiece # Periorbital sites
Parameters,
energy (mJ/mb)
Passes Erythema
Wrinkle reduction
(two out of three graders using 0–9 scale)
Stacked Total
% of test sites
at 1 month
% of test sites
at 3 months
% of test sites with
score improvement1
% of test sites with
score improvement2
2,790 4 8–9 0 1–2 50 50 50 0
2,940 5 3–6 0 1 0 0 60 20
2,940 8 3–6 0 4–6 38 12 88 38
2,940 4 5 2 6–8 75 25 100 50
TABLE 3b. Perioral Wrinkle Reduction After Micro-Fractional Erbium Treatment
Handpiece # Perioral sites
Parameters,
energy (mJ/mb)
Passes Erythema
Wrinkle reduction
(two out of three graders using 0–9 scale)
Stacked Total
% of test sites
at 1 month
% of test sites
at 3 months
% of test sites with
score improvement1
% of test sites with
score improvement 2
2,790 6 6–9 0 1 0 0 16 0
2,940 6 5 0–2 2–3 16 0 33 0
2,940 7 5 1–2 4–6 29 29 57 57
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parameters were varied for each patient from side to side,
left and right sides were evaluated as independent test
sites. Results for the 2,790 and 2,940 nm handpieces
summarized in Tables 3a and 3b include the percentage of
tested areas having erythema at 1 and 3 months and the
percentage of areas with wrinkle score reductions.
The number of treated sites with at least two of the three
graders giving a score reduction of one or more (2nd to last
column) or two or more (last column) was divided by the
total number of treatment sites to determine percentage.
A total of 12 periorbital sites were treated with four
passes or more and over 90% had 1 score wrinkle
reduction (0–9 scale) and 42% had2. The overall average
reduction in the periorbital wrinkle score (post-pre) was
statistically significant (t-test or Wilcoxon signed-rank
statistic: 1.26 1.11, n¼ 21, P<0.0001). The use of four
or more passes resulted in an average reduction of 1.5, but
with the addition of double-stacked pulses the average
reduction increased to 2.4. Figure 10 shows before (top) and
after (bottom) photos following a single 2,940 nm periorbi-
tal treatment of six passes at 5 mJ/mb, 5 milliseconds pulse
width and density of 920 mb/cm2 per pass. The left side
received double-stacked pulses at two pulses per second
for the first two passes and shows greater reduction
in wrinkles, but mild post-inflammatory erythema at
3 months. Instances of erythema, a mild pink to slight red
below the eye, were present at the 3-month observation in
2 of 17 cases with 2,940 nm treatments. Because erythema
for the 2,790 nm treatments (see Table 3a) appeared to
last longer, testing was subsequently focused on defining
parameters for the 2,940 nm handpiece.
Substantial improvements in perioral wrinkles were
observed with aggressive treatments. For the seven treat-
ment sites receiving four or more passes over 50% had 2
score improvement. The overall average reduction in
wrinkle score (post-pre) was statistically significant (t-test
or Wilcoxon signed-rank statistic: 0.74 1.43, n¼ 19,
P<0.05). Those receiving four or more passes had an
average reduction of 1.5 and for the four cases with
improvements the average reduction was 2.7. Figure 11
shows before (top) and after (bottom) photos following a
2,940 nm perioral treatment at 5 mJ/mb, 5 milliseconds
pulse width and density of 920 mb/cm2 per pass. The
firstpass onboth sideswasdouble-stackedat twopulsesper
second. The right side had an additional double-stacked
pass and six passes total, while the left side had four total
passes. The right side shows greater reduction in wrinkles,
but mild post-inflammatory erythema at 3 months.
These clinical and histologic findings demonstrate the
efficacy of micro-fractional ablative treatments in wrinkle
Fig. 8. Appearance of skin surface following fractional skin ablation from a single 5 mJ/mb,
2 milliseconds pulse of the 2,940 nm device at a density of 920 mb/cm2 shows rapid healing.
By day 7 the skin surface is restored.
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reduction. In addition, this new approach is associated
with mild side effects and reduced downtime compared to
traditional ablative resurfacing methods.
DISCUSSION
The novel micro-fractional ablative device investigated
in this study provides a wide range of new capabilities for
skin rejuvenation. The depth and width of the ablated
microcolumns and extent of surrounding coagulation can
be varied and used to design procedures targeted for
specific indications and areas. With a user selectable optic
of 920 mb/cm2, both erbium lasers caused similar ablative
damage profiles with diameters for single-pulse mode
ranging from 60 to 100 mm and ablation depths from 20 to
250 mm at energy settings up to 5 mJ/mb. Stacked pulses
provided even deeper columns as compared to respective
single pulses. Coagulation zones around the ablatedmicro-
columns varied in thickness from 5 to 25 mm and depended
upon pulse width and wavelength (Figs. 3–6). At equiv-
alent settings, the 2,790 nm wavelength handpiece
generated somewhat greater thermal damage than the
2,940 nm handpiece. Traditional erbium ablation has
very minimal zones of thermal injury due to the combina-
tion of high water absorption and short-pulse mode. One
novel feature of the 2,940 nm system is its ability to provide
smooth, long (millisecond range) pulses. This feature,
combined with the micro-fractional delivery configuration,
produced relatively large consistent zones of coagulation
surrounding the ablative microcolumns. Because the
2,940 nm handpiece could provide both ablative (short-
pulse) and ablative plus coagulative (long-pulse) modes of
micro-fractional treatments, efforts were subsequently
focused on evaluating the 2,940 nm handpiece to define
safety limits and optimum treatment parameters for
further clinical investigations.
The treatment tests with single-pass parameters clearly
demonstrate the safety and rapid healing of the micro-
fractional ablative approach. Histologic findings confirm
that the epidermis undergoes a rapid re-epithelization
(<24 hours) followingmicro-ablative ablation at settings of
9–12mJ/mb (Fig. 7, histology from 2,790 not shown). Based
upon the observed ablative column diameters of 75–
100 mm, approximately 4–5% of the skin surface is ablated
in each pass when using an optical tip with a 920 mb/cm2
density. With multiple passes, however, there is an
Fig. 9. The rapid healing frommulti-pass treatment with the 2,940 nmhandpiece is shown in
the sequence of pictures. The top row from left to right shows the periorbital test area taken
before, immediately after, and 4 days post-treatment. The bottom row shows the test area 7
and14dayspost-treatment. The subject receivedperiorbital treatment of fourpasses of 920mb/
cm2 per pass, each at 5 mJ/mb at 5 milliseconds pulse width. The oozing that is evident
immediately after treatment resolved by day 2 and necrotic tissue was replaced with a faint
pink skin by day 4. Natural healthy skin tone and texture was fully restored by 1 week.
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Fig. 10. Before (top) and3-monthpost-treatmentphotos (bottom) followinga single 2,940nm
periorbital treatment of six passes at 5mJ/mb, 5milliseconds pulsewidth anddensity of 920 mb/
cm2 per pass. The left side received double stacked pulses at two pulses per second for the first
two passes and shows greater reduction in wrinkles, but mild post-inflammatory erythema.
Fig. 11. Before (top) and3-monthpost-treatment photos (bottom) followinga single 2,940nm
perioral treatment at 5 mJ/mb, 5 milliseconds pulse width and density of 920 mb/cm2 per pass.
The first pass on both sides was double stacked at two pulses per second. The right side had an
additional double stacked pass and six passes total,while the left side hada total of four passes.
The right side shows greater reduction in wrinkles, but mild post-inflammatory erythema.
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accumulating effect on the skin and an increasing proba-
bility that micro-columns will merge or overlap enlarging
the zones of thermal injury ultimately extending the
healing time. If the density is great enough, the injury is,
in essence, a full-ablative procedure. A series of clinical
tests were performed, therefore, varying density from 1 to
8 passes at periorbital and perioral areas to determine
the skin tolerance and efficacy following a single ablative
treatment that involves 5–40% of the skin.
The advantages of the fractional approachwere confirmed
by the mild to moderate skin reactions and rapid healing
after treatments. Subjects could apply make-up and mois-
turizers after 4 dayswith onlymild lingering erythema that
generally resolved in 1 month. While not quantified in this
study, UV-induced pigment irregularities were also notice-
ably reduced after treatment. At 3 months there is no
evidence of scarring or long-term dyspigmentation. For the
periorbital and perioral tested areas wrinkle reduction
tended to improve with increasing number of passes and
stacking of pulses. For periorbital treatments of four passes
ormore over 90%had1 scorewrinkle reduction (0–9 scale)
and 42% had 2. For perioral wrinkles over 50%
had substantial improvements (2). For some subjects
the reduction in wrinkles was substantial and similar to
the improvement observed in full-ablative procedures.
Because of the large subject-to-subject variability, however,
a side-by-side comparative study would be required before
drawing conclusions regarding efficacy relative to tradi-
tional full-surface ablative skin resurfacing.
In conclusion, micro-fractional ablative treatment with
2,790 and 2,940 nm erbium lasers resulted in the safe
and effective reduction in mild to moderate rhytides. In
comparison to full-surfaceablative skin resurfacing there is
very rapid re-epithelization, limited adverse side effects
and reduced subject downtime to 4 days or less.
The size, density, and damage profile of the fractional
zones that maximize efficacy with minimal downtime and
highmargin of safety arenot known.The size anddensity of
the individual fractional zones as recently reported [20–24]
show a significant influence on the healing time, potential
for adverse effects and overall response. With the erbium
micro-fractional handpiece many combinations of depths,
density, andpatterns of damageare possible thusmaking it
a useful tool in the arsenal of laser methods available to
achieve the ultimate goal of consistent and substantial
efficacy for severe rhytides with reduced down-time and
high safety margins.
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